Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

NCT ID: NCT00868959

Last Updated: 2016-04-14

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

817 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-04-30

Study Completion Date

2013-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This clinical study is designed to test the hypothesis that lurasidone is effective, tolerable, and safe for the treatment of patients with bipolar I depression

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bipolar Depression

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

lurasidone

Group Type EXPERIMENTAL

lurasidone

Intervention Type DRUG

Lurasidone 20-120 mg/d Flexibly Dosed - 24 weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

lurasidone

Lurasidone 20-120 mg/d Flexibly Dosed - 24 weeks

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject is judged by the investigator to be suitable for participation in a 24-week clinical trial involving open-label lurasidone treatment
* Subject has completed the 6-week treatment period and all required assessments on the final study visit (Day 42, Visit 8) of either Study D1050235, NCT#00868452 or Study D1050236, NCT#008668699.

Exclusion Criteria

* Imminent risk of suicide, injury to self or to others, or damage to property
* Subject has evidence of severe movement disorders.
* Subject tests positive for drugs of abuse (at Visit 8 in Study D1050235, NCT#00868452 or D1050236, NCT#008688699).
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sumitomo Pharma America, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Medical Director, MD

Role: STUDY_DIRECTOR

Sumitomo Pharma America, Inc.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Woodland International Research Inc

Little Rock, Arkansas, United States

Site Status

South Coast Clinical Trials Inc.

Anaheim, California, United States

Site Status

Catalina Research Institute

Chino, California, United States

Site Status

Clinical Innovations Inc.

Costa Mesa, California, United States

Site Status

Synergy Escondido

Escondido, California, United States

Site Status

Collaborative Neuroscience Network Inc

Garden Grove, California, United States

Site Status

Cedars-Sinai Medical Center

Los Angeles, California, United States

Site Status

Florida Clinical Research Center LLC

Maitland, California, United States

Site Status

Excell Research, Inc

Oceanside, California, United States

Site Status

University of California at Irvine Medical Center

Orange, California, United States

Site Status

CNRI - Los Angeles LLC

Pico Rivera, California, United States

Site Status

Clinical Innovations Inc.

Riverside, California, United States

Site Status

California Neuropsychopharmacology Clinical Research Instit

San Diego, California, United States

Site Status

Artemis Institute for Clinical Research LLC

San Diego, California, United States

Site Status

Sharp Mesa Vista Hospital

San Diego, California, United States

Site Status

Clinical Innovations Inc.

Santa Ana, California, United States

Site Status

Stanford University School of Medicine

Stanford, California, United States

Site Status

Collaborative Neuroscience Network Inc.

Torrance, California, United States

Site Status

University of Colorado

Aurora, Colorado, United States

Site Status

MCB Clinical Research Centers-Colorado Springs

Colorado Springs, Colorado, United States

Site Status

Florida Clinical Research Center LLC

Bradenton, Florida, United States

Site Status

Florida Clinical Research Center LLC

Fruitland Park, Florida, United States

Site Status

Accurate Clinical Trials

Kissimmee, Florida, United States

Site Status

Clinical Neuroscience Solutions INc.

Orlando, Florida, United States

Site Status

University of South Florida Institute - Tampa

Tampa, Florida, United States

Site Status

Janus Center for Psychiatric Research

West Palm Beach, Florida, United States

Site Status

Northwest Behavioral Research Center

Rosewekk, Georgia, United States

Site Status

Institute for Behavioral Medicine LLC

Smyrna, Georgia, United States

Site Status

American Medical Research

Oak Brook, Illinois, United States

Site Status

Lake Charles Clinical Trials LLC

Lake Charles, Louisiana, United States

Site Status

Booker, J. Gary, MD. APMC

Shreveport, Louisiana, United States

Site Status

Sheppard Pratt Health System

Baltimore, Maryland, United States

Site Status

Capitol Clinical Research

Rockville, Maryland, United States

Site Status

Precise Research Centers

Flowood, Mississippi, United States

Site Status

Midwest Research Group

Saint Charles, Missouri, United States

Site Status

CRI Worldwide, LLC

Willingboro, New Jersey, United States

Site Status

Albuquerque Neuroscience Inc.

Albuquerque, New Mexico, United States

Site Status

Social Psychiatry Research Institute

Brooklyn, New York, United States

Site Status

Neurobehavioral Research, Inc

Cedarhurst, New York, United States

Site Status

Village Clinical Research Inc.

New York, New York, United States

Site Status

Medical & Behavioral Health Research PC

New York, New York, United States

Site Status

Finger Lakes Clinical Research

Rochester, New York, United States

Site Status

Zarzar Psychiatric Associates PLLC

Raleigh, North Carolina, United States

Site Status

Richard H. Weisler & Associates

Raleigh, North Carolina, United States

Site Status

Quest Therapeutics

Avon Lake, Ohio, United States

Site Status

Psychiatric Professional Services Inc

Cincinnati, Ohio, United States

Site Status

Mood Disorders Program-UHCMC

Cleveland, Ohio, United States

Site Status

MetroHealth System

Cleveland, Ohio, United States

Site Status

Midwest Clinical Research Center

Dayton, Ohio, United States

Site Status

Summit Research Network (Oregon) Inc.

Portland, Oregon, United States

Site Status

Lehigh Valley Hospital

Allentown, Pennsylvania, United States

Site Status

Clinical Neuroscience Solutions Inc.

Memphis, Tennessee, United States

Site Status

FutureSearch Clinical Trials LP

Austin, Texas, United States

Site Status

FutureSearch Trials

Dallas, Texas, United States

Site Status

Pillar Clinical Research LLC

Dallas, Texas, United States

Site Status

Red Oak Psychiatry Associates, PA

Houston, Texas, United States

Site Status

Wharton Research Center

Wharton, Texas, United States

Site Status

Summit Research Network (Seattle) LLC

Seattle, Washington, United States

Site Status

Clinical Research Group Edmonton

Edmonton, Alberta, Canada

Site Status

Okanagan Clinical Trials

Kelowna, British Columbia, Canada

Site Status

Pierre-Janet Hospital

Gatineau, Quebec, Canada

Site Status

Hopital Louis-H Lafontaine

Montreal, Quebec, Canada

Site Status

Centro de Investigaciones y Proyectos en Neurociencias CIPNA Investigations

Barranquilla, , Colombia

Site Status

E.S.E. Hospital Mental de Antioquia

Bello, , Colombia

Site Status

Centro de Investigacion y Atencion para la Salud Mental

Bogotá, , Colombia

Site Status

Centro de Investigaciones del Sistema Nerviosa Limitada-Gr

Bogotá, , Colombia

Site Status

Saint Anne, s.r.o., Psychiatricke oddeleni

Brno - Mesto, , Czechia

Site Status

BIALBI s.r.o. Psychiatricke oddeleni

Litoměřice, , Czechia

Site Status

Psychiatricka ambulance Prosek

Lovosicka, , Czechia

Site Status

Vojenska nemocnice Olomouc

Olomouc, , Czechia

Site Status

Clintrial, s.r.o.

Prague, , Czechia

Site Status

Psychiatry Trial s.r.o.

Prague, , Czechia

Site Status

Medical Services Prague s.r.o.

Prague, , Czechia

Site Status

Hopital Caremeau, Service de Psychiatrie A

Nîmes, , France

Site Status

Zans Ritter, Marcel

Orvault, , France

Site Status

S V Medical College

Tirupati, Andh Prad, India

Site Status

Vijayawada Institute of Mental Health and Neurosciences, Psychiatry

Vijaywada, Andh Prad, India

Site Status

Brain Mind Behaviour Neurosciences Research Institute

Visakhapatnam, Andh Prad, India

Site Status

Seth K M School of P G Medicine & Research

Ahmedabad, Gujarat, India

Site Status

Mental Illness Treatment Rehabilitation Foundation (MITR)

Ahmedabad, Gujarat, India

Site Status

Brij Psychiatry Hospital & Muskaan Research Centre

Vadodara, Gujarat, India

Site Status

Spandana Nursing Home

Bangalore, Karna, India

Site Status

Abhava Hospital

Bangalore, Karna, India

Site Status

K.S. Hegde Medical Academy

Mangalore, Karna, India

Site Status

Shanti Nursing Home

Aurangabad, Mahara, India

Site Status

Poona Hospital & Research Center

Pune, Mahara, India

Site Status

Mahatma Gandhi Institute of Medical Sciences

Wardha, Mahara, India

Site Status

Cosmos Hospitals-Delhi Psychiatry Center-Dept. of Psychiatry

Delhi, National Capital Territory of Delhi, India

Site Status

Dr. Tambi's Neuropsychiatry Center

Jaipur, Rajaasthan, India

Site Status

R.K. Yadav Memorial Mental Health & De-Addiction Hospital Psychiatry

Jaipur, Rajasthan, India

Site Status

Mahendru Psychiatric Centre

Kanpur, Uttar Prad, India

Site Status

Manobal Med. Research Centre

Lucknow, Uttar Prad, India

Site Status

Shree Hatkesh Health Foundation

Gujarat, , India

Site Status

Samvedna Hospitals

Gujarat, , India

Site Status

Chhatrapati Shahuji Maharaj

Lucknow, , India

Site Status

Sujata Dirla Hospital & Research Centre

Mahara, , India

Site Status

Ongata Hospital

Hachioji-shi, , Japan

Site Status

Kohnodai Hp., National Center for Global Health and Medicine

Ichikawa-sha, , Japan

Site Status

NHO Hizen Psychiatric Center

Kanzaki-gun, , Japan

Site Status

National Center of Neurology and Psychiatry

Kodaira-shi, , Japan

Site Status

Asakayama General Hospital

Sakaishi, , Japan

Site Status

Osaka Institute of Clinical Psychiatry Shin-abuyama Hospital

Takatsuki-shi, , Japan

Site Status

Neuromeda, JSC

Kaunas, , Lithuania

Site Status

Kaunas Hospital Division Marui Hospital, Public Institution

Kaunas, , Lithuania

Site Status

Silutes Mental Health and Psychotherapy Center, JSC

Šilutė, , Lithuania

Site Status

Seskines Outpatient Clinic, Public Institution

Vilnius, , Lithuania

Site Status

Zirmunai Mental Health Center, Public Institution

Vilnius, , Lithuania

Site Status

Hospital Nacional Hipolito Unanue

Lima, , Peru

Site Status

Hospital Nacional Arzobispo Loayza

Lima, , Peru

Site Status

Clinica Vesalio

Lima, , Peru

Site Status

ZOZ Poradnia Zdrowia Psychicznego

Chełmno, , Poland

Site Status

Praktyka Lekarska Sensorium S.M.O.

Skorzewo, , Poland

Site Status

Spitalul Clinic de Urgenta Militar Central

Bucharest, , Romania

Site Status

Spitalul Clinic de Psihaiatrie Prof. Dr. Alexandru Obregia

Bucharest, , Romania

Site Status

Spitalul Clinic Judetean de Urgenta Cluj

Cluj-Napoca, , Romania

Site Status

Spitalul Clinic de Neuropsihiatrie Craiova

Craiova, , Romania

Site Status

Centrul de Recuperare si Reabilitare Gura Ocnitei

Gura Ocniței, , Romania

Site Status

Spitalul Clinic de Neurologie si Psihiatrie Oradea

Oradea, , Romania

Site Status

Russian State Medical University of RosZdrav

Moscow, , Russia

Site Status

Moscow Medical Academy name I.M. Sechenov

Moscow, , Russia

Site Status

City Psychiatric Hospital #2 of St. Nikolay Chudotvorets

Saint Petersburg, , Russia

Site Status

Bekhterev Scientific Research Psychoneurological Institute

Saint Petersburg, , Russia

Site Status

Psychoneurology Dispensary #4

Saint Petersburg, , Russia

Site Status

LLC International Medical Centre "SOGAZ"

Saint Petersburg, , Russia

Site Status

Nemocnica s poliklinikou Prievidza so sidlom v Bojniciach Psychiatricke oddelenie

Bojnice, , Slovakia

Site Status

Psychiatricka ambulancia Mentum, s.r.o.

Bratislava, , Slovakia

Site Status

Univerzitna nemocnica Bratislava, Nemocnica Ruzinov Psychiatricka klinika

Bratislava, , Slovakia

Site Status

Nemocnica s poliklinikou Liptovsky Mikulas Psychiatricke oddelenie

Liptovský Mikuláš, , Slovakia

Site Status

PsychoLine s.r.o. Psychiatricka ambulancia

Rimavská Sobota, , Slovakia

Site Status

Nemocnica s poliklinikou sv Barbory Roznava a.s. Psychiatricke oddelenie

Rožňava, , Slovakia

Site Status

Centrum zdravia R. B.K. s.r.o. Psychiatricka ambulancia

Svidník, , Slovakia

Site Status

Pro mente sana s.r.o. Psychiaricka ambulancia

Trenčín, , Slovakia

Site Status

Groote Schuur Hospital

Cape Town, , South Africa

Site Status

Cape Trial Centre

Cape Town, W. Cape, , South Africa

Site Status

Paarl Medical Centre

Paarl, W. Cape, , South Africa

Site Status

Clinika, Murray and Roberts Building

Port Elizabeth, , South Africa

Site Status

Dey Clinic

Pretoria, Gauteng, , South Africa

Site Status

Vereeniging Medi-Clinic

Vereeniging, Free State, , South Africa

Site Status

Regional Clinical Hospital n.a.l.l.

Dnipropetrovsk, , Ukraine

Site Status

Com. Inst. "Dnipropetrovsk Reg. Cl. Psych. Hosp." DSMA

Dnipropetrovsk, , Ukraine

Site Status

Reg. Clin. Psychiatric Hosp. DSMU n.af.M.Gorkiy

Donetsk, , Ukraine

Site Status

St.In."Inst. of Neurol., Psych. and Narcol. of the AMSU"

Kharkiv, , Ukraine

Site Status

Kherson Regional Psychiatric Hospital

Kherson, , Ukraine

Site Status

Kyiv City Psychoneurological Hospital #2

Kviv, , Ukraine

Site Status

Lviv Reg.St.Cl.Psych.Hosp.Dept.#20, LNMU n.a.D. Halytskiy Chair of Psychiatry, Psychology and Sexololgy

Lviv, , Ukraine

Site Status

Odesa SMU, based on Odessa Reg. Psychiatric Hosp.#1

Odesa, , Ukraine

Site Status

Reg. Ci.Ps.H.n.a.O.F.Maltsev, Fem.Ac.Gen.Ps. D.5B,HESIU UM

Poltava, , Ukraine

Site Status

Crimean republican Clinical Psychiatric Hospital

Simferopol, , Ukraine

Site Status

Ternopil Regional Municipal Dispensary, Narcology Dept., Ch. of Neurol. Psych. Narcol. & Med. Psychol.

Ternopil, , Ukraine

Site Status

Reg. Psych. Hosp.n.a. O.Yuschenko, Dept. #121 VNMI

Vinnitsia, , Ukraine

Site Status

Zapor Reg. Cl. Hosp., Zaporizhzhia SMU, ENT Dept.

Zaporizhzhia, , Ukraine

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Canada Colombia Czechia France India Japan Lithuania Peru Poland Romania Russia Slovakia South Africa Ukraine

References

Explore related publications, articles, or registry entries linked to this study.

Forester BP, Sajatovic M, Tsai J, Pikalov A, Cucchiaro J, Loebel A. Safety and Effectiveness of Long-Term Treatment with Lurasidone in Older Adults with Bipolar Depression: Post-Hoc Analysis of a 6-Month, Open-Label Study. Am J Geriatr Psychiatry. 2018 Feb;26(2):150-159. doi: 10.1016/j.jagp.2017.08.013. Epub 2017 Oct 10.

Reference Type DERIVED
PMID: 29146409 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EUDRACT No. 2008-007483-42

Identifier Type: -

Identifier Source: secondary_id

D1050256

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Lurasidone Pediatric Bipolar Study
NCT02046369 COMPLETED PHASE3
Pediatric Open-Label Extension Study
NCT01914393 COMPLETED PHASE3
Lurasidone Pediatric Autism Study
NCT01911442 COMPLETED PHASE3